title: Engineered CRISPR/Cas13d Virus-Like Particles for Potent, Safe Gene Therapy of Idiopathic Pulmonary Fibrosis
design: Mouse were given tracheal injections of BLM, followed by tracheal injections of PBS every two days starting on day 7, for a total of four injections. Lung tissues were collected for sequencing, with the samples divided into three parts for sequencing.